BioArctic AB (BRCTF)
29.44
-7.48
(-20.27%)
USD |
OTCM |
Oct 08, 16:00
BioArctic Profit Margin (Quarterly) : -4.51% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.51% |
| March 31, 2026 | 48.54% |
| December 31, 2025 | -4.80% |
| September 30, 2025 | -65.15% |
| June 30, 2025 | 24.62% |
| March 31, 2025 | 79.21% |
| December 31, 2024 | -31.08% |
| September 30, 2024 | -25.62% |
| June 30, 2024 | -137.3% |
| March 31, 2024 | -194.2% |
| December 31, 2023 | -791.4% |
| September 30, 2023 | 59.83% |
| June 30, 2023 | -3.78K% |
| March 31, 2023 | 74.69% |
| December 31, 2022 | -2.77K% |
| September 30, 2022 | 62.68% |
| June 30, 2022 | -1.08K% |
| March 31, 2022 | -1.18K% |
| December 31, 2021 | -402.8% |
| September 30, 2021 | -950.7% |
| Date | Value |
|---|---|
| June 30, 2021 | -467.4% |
| March 31, 2021 | -405.3% |
| December 31, 2020 | -157.9% |
| September 30, 2020 | -195.8% |
| June 30, 2020 | -545.5% |
| March 31, 2020 | 9.76% |
| December 31, 2019 | -64.71% |
| September 30, 2019 | -40.38% |
| June 30, 2019 | 58.52% |
| March 31, 2019 | 21.50% |
| December 31, 2018 | 65.05% |
| September 30, 2018 | 27.49% |
| June 30, 2018 | 9.79% |
| March 31, 2018 | 29.48% |
| December 31, 2017 | 23.20% |
| September 30, 2017 | -0.37% |
| June 30, 2017 | 7.25% |
| December 31, 2016 | 79.38% |
| September 30, 2016 | -655.9% |
| June 30, 2016 | -868.6% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Hansa Biopharma AB | -541.7% |
| Swedish Orphan Biovitrum AB | 14.00% |
| Diamyd Medical AB | -184.8K% |
| BONESUPPORT HOLDING AB | 23.02% |
| BioInvent International AB | -964.0% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 5.57% |
| Return on Assets | 4.36% |
| Return on Invested Capital | 5.42% |
| Gross Profit Margin (Quarterly) | 91.24% |
| Operating Margin (Quarterly) | -1.01% |
| Return on Net Operating Assets | 93.05% |